SITC - 33rd Annual Meeting

Description

The 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) scheduled to take place Nov. 7-11, 2018 at the Walter E. Washington Convention Center in Washington, D.C. 

PLENARY SESSIONS

Cell-Based Therapies for Solid Tumors
Immune Checkpoints— Beyond PD 1
Next Generation Bispecifics and Antibody-Like Molecules
Understanding the Tumor Microenvironment

CONCURRENT SESSIONS

Advances in Immunotherapy in:

  • Pediatric Malignancies
  • Lung, Head and Neck Cancer
  • GI and Pancreatic Cancer
  • GU Tumors
  • Breast and Ovarian Cancers
  • Hematologic Malignancies

Basic Biology of Tregs
Clinical Management of Cell Therapy Administration
Clinical Trial Design/Surrogate Efficacy Markers
Cytokines Reinvented
Early Phase 1 Clinical Trials
Metabolic Manipulation of the TME
Myeloid Derived Suppressive Populations
Role of B cells in Immunotherapy Toxicity